Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer

Madan, RA; Bilusic, M; Stein, MN; Donahue, RN; Arlen, PM; Karzai, F; Plimack, E; Wong, YN; Geynisman, DM; Zibelman, M; Mayer, T; Strauss, J; Chen, G; Rauckhorst, M; McMahon, S; Couvillon, A; Steinberg, S; Figg, WD; Dahut, WL; Schlom, J; Gulley, JL

Madan, RA (通讯作者),NCI, 10 Ctr Dr,Rm 13n240b, Bethesda, MD 20892 USA.

ONCOLOGIST, 2023; 28 (7): 642

Abstract

Background: Before 2018, there was no standard of care for non-metastatic (M0) castration resistant prostate cancer nmCRPC. Androgen receptor antagoni......

Full Text Link